Global Iopamidol API Market Research Report 2024

Publication ID:

PB503248023

Publication Date:

March 21, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

Iopamidol is an active pharmaceutical ingredient (API) used in medical imaging procedures, particularly in X-ray and CT scan contrast agents.
The global Iopamidol API market was valued at US$ 245 million in 2023 and is anticipated to reach US$ 326.3 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.
The market for Iopamidol API is driven by the increasing demand for medical imaging technologies and diagnostic procedures. Iopamidol is a water-soluble iodinated contrast medium used to enhance visibility and improve the accuracy of medical imaging. The demand for reliable and safe contrast agents contributes to the growth of this market.
This report aims to provide a comprehensive presentation of the global market for Iopamidol API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Iopamidol API.
Report Scope
The Iopamidol API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Iopamidol API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Iopamidol API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bracco Imaging
Stellite
Stellite
Segment by Type
Original Drug
Generic Drug
Segment by Application
Hospitals
Clinics
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Iopamidol API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Iopamidol API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Iopamidol API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Iopamidol API Market Overview
1.1 Product Definition
1.2 Iopamidol API Segment by Type
1.2.1 Global Iopamidol API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Iopamidol API Segment by Application
1.3.1 Global Iopamidol API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Market Growth Prospects
1.4.1 Global Iopamidol API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Iopamidol API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Iopamidol API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Iopamidol API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Iopamidol API Production Market Share by Manufacturers (2019-2024)
2.2 Global Iopamidol API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Iopamidol API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Iopamidol API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Iopamidol API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Iopamidol API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Iopamidol API, Product Offered and Application
2.8 Global Key Manufacturers of Iopamidol API, Date of Enter into This Industry
2.9 Iopamidol API Market Competitive Situation and Trends
2.9.1 Iopamidol API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Iopamidol API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Iopamidol API Production by Region
3.1 Global Iopamidol API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Iopamidol API Production Value by Region (2019-2030)
3.2.1 Global Iopamidol API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Iopamidol API by Region (2025-2030)
3.3 Global Iopamidol API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Iopamidol API Production by Region (2019-2030)
3.4.1 Global Iopamidol API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Iopamidol API by Region (2025-2030)
3.5 Global Iopamidol API Market Price Analysis by Region (2019-2024)
3.6 Global Iopamidol API Production and Value, Year-over-Year Growth
3.6.1 North America Iopamidol API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Iopamidol API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Iopamidol API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Iopamidol API Production Value Estimates and Forecasts (2019-2030)
4 Iopamidol API Consumption by Region
4.1 Global Iopamidol API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Iopamidol API Consumption by Region (2019-2030)
4.2.1 Global Iopamidol API Consumption by Region (2019-2024)
4.2.2 Global Iopamidol API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Iopamidol API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Iopamidol API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Iopamidol API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Iopamidol API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Iopamidol API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Iopamidol API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Iopamidol API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Iopamidol API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Iopamidol API Production by Type (2019-2030)
5.1.1 Global Iopamidol API Production by Type (2019-2024)
5.1.2 Global Iopamidol API Production by Type (2025-2030)
5.1.3 Global Iopamidol API Production Market Share by Type (2019-2030)
5.2 Global Iopamidol API Production Value by Type (2019-2030)
5.2.1 Global Iopamidol API Production Value by Type (2019-2024)
5.2.2 Global Iopamidol API Production Value by Type (2025-2030)
5.2.3 Global Iopamidol API Production Value Market Share by Type (2019-2030)
5.3 Global Iopamidol API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Iopamidol API Production by Application (2019-2030)
6.1.1 Global Iopamidol API Production by Application (2019-2024)
6.1.2 Global Iopamidol API Production by Application (2025-2030)
6.1.3 Global Iopamidol API Production Market Share by Application (2019-2030)
6.2 Global Iopamidol API Production Value by Application (2019-2030)
6.2.1 Global Iopamidol API Production Value by Application (2019-2024)
6.2.2 Global Iopamidol API Production Value by Application (2025-2030)
6.2.3 Global Iopamidol API Production Value Market Share by Application (2019-2030)
6.3 Global Iopamidol API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Bracco Imaging
7.1.1 Bracco Imaging Iopamidol API Corporation Information
7.1.2 Bracco Imaging Iopamidol API Product Portfolio
7.1.3 Bracco Imaging Iopamidol API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Bracco Imaging Main Business and Markets Served
7.1.5 Bracco Imaging Recent Developments/Updates
7.2 Stellite
7.2.1 Stellite Iopamidol API Corporation Information
7.2.2 Stellite Iopamidol API Product Portfolio
7.2.3 Stellite Iopamidol API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Stellite Main Business and Markets Served
7.2.5 Stellite Recent Developments/Updates
7.3 Stellite
7.3.1 Stellite Iopamidol API Corporation Information
7.3.2 Stellite Iopamidol API Product Portfolio
7.3.3 Stellite Iopamidol API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Stellite Main Business and Markets Served
7.3.5 Stellite Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Iopamidol API Industry Chain Analysis
8.2 Iopamidol API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Iopamidol API Production Mode & Process
8.4 Iopamidol API Sales and Marketing
8.4.1 Iopamidol API Sales Channels
8.4.2 Iopamidol API Distributors
8.5 Iopamidol API Customers
9 Iopamidol API Market Dynamics
9.1 Iopamidol API Industry Trends
9.2 Iopamidol API Market Drivers
9.3 Iopamidol API Market Challenges
9.4 Iopamidol API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Bracco Imaging
Stellite
Stellite

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂